Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxaquim is a leading European chemical manufacturer and the world's second-largest producer of oxalic acid and its derivatives. Headquartered in Spain, the company is a critical supplier to the global pharmaceutical industry, providing high-purity intermediates used in the synthesis and purification of active pharmaceutical ingredients, most notably antibiotics. Their product range includes oxalic acid dihydrate and various oxalates utilized in dental applications and medical devices. Oxaquim operates state-of-the-art manufacturing facilities that adhere to rigorous quality standards, ensuring their chemicals meet the precision required for life science applications. The company maintains a strong international presence, exporting its specialized chemical solutions to over 80 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxaquim.